GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Short-Term Debt

Cyfuse Biomedical KK (TSE:4892) Short-Term Debt : 円568.00 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Short-Term Debt?

Cyfuse Biomedical KK's Short-Term Debt for the quarter that ended in Dec. 2023 was 円568.00 Mil.

Cyfuse Biomedical KK's quarterly Short-Term Debt declined from Jun. 2023 (円500.01 Mil) to Sep. 2023 (円470.23 Mil) but then increased from Sep. 2023 (円470.23 Mil) to Dec. 2023 (円568.00 Mil).

Cyfuse Biomedical KK's annual Short-Term Debt increased from Dec. 2021 (円201.22 Mil) to Dec. 2022 (円545.14 Mil) and increased from Dec. 2022 (円545.14 Mil) to Dec. 2023 (円568.00 Mil).


Cyfuse Biomedical KK Short-Term Debt Historical Data

The historical data trend for Cyfuse Biomedical KK's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Short-Term Debt Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Short-Term Debt
73.46 201.22 545.14 568.00

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only 545.14 522.58 500.01 470.23 568.00

Cyfuse Biomedical KK Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Cyfuse Biomedical KK Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyfuse Biomedical KK (TSE:4892) Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines